Hypoxia modification with radiotherapy for bladder cancer

被引:0
作者
Mary Gospodarowicz
机构
[1] Princess Margaret Hospital,
[2] University of Toronto,undefined
来源
Nature Reviews Clinical Oncology | 2011年 / 8卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The outcomes in bladder cancer treated with radiotherapy are suboptimal. Recently, Hoskin et al. reported improved survival in patients with bladder cancer treated with radiation therapy with concurrent hypoxia-modification therapy. These results are promising but must be viewed in the context of previous studies and alternative treatment approaches.
引用
收藏
页码:129 / 130
页数:1
相关论文
共 20 条
  • [1] Ott OJ(2009)Radiochemotherapy for bladder cancer Clin. Oncol. (R. Coll. Radiol.) 21 557-565
  • [2] Kaanders JH(2004)Clinical studies of hypoxia modification in radiotherapy Semin. Radiat. Oncol. 14 233-240
  • [3] J. Bussink J(1986)Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer Int. J. Radiat. Oncol. Biol. Phys. 12 1343-1346
  • [4] van der Kogel AJ(2010)Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma J. Clin. Oncol. 28 4912-4918
  • [5] Sealy R(2007)Radiotherapy for bladder cancer Urology 69 80-92
  • [6] Cridland S(2010)Adaptive management of bladder cancer radiotherapy Semin. Radiat. Oncol. 20 116-120
  • [7] Barry L(2010)Behavior of lipiodol markers during image guided radiotherapy of bladder cancer Int. J. Radiat. Oncol. Biol. Phys. 77 309-314
  • [8] Norris R(2009)Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer Radiother. Oncol. 93 364-367
  • [9] Hoskin PJ(2005)What is the role of radiotherapy in bladder-preserving cancer therapy? Nat. Clin. Pract. Oncol. 2 4-5
  • [10] Rojas AM(1996)Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group J. Clin. Oncol. 14 2901-2907